Benefits of NIV for COVID-19
The role of CPAP and High-Flow in treating COVID-19 patients
As the Coronavirus outbreak continues, a pandemic on this scale places immense pressure on ICUs around the world.
Lawton et al describe the impact of early CPAP on reducing ICU demand; read the Full Paper
“Based on our experience, we intend to continue early CPAP during any second wave, and we would recommend other centres consider the use of CPAP and proning in any patient with more severe COVID-19.”
The role of CPAP in avoiding intubation
A recent publication in the European Respiratory Journal suggests that CPAP can avoid intubation;
Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study, Oranger M et al. Read the full paper.
As the pandemic evolves, it is clear that CPAP and HFOT are critical in the treatment of COVID-19 around the world.
The FD140 features in this clip from the BBC Coronavirus Special, Episode 2, filmed in London during the peak of the UK outbreak.
Many of our global distributors also reported positive feedback on the use of the FD140 to deliver CPAP.
“The benefit of the FD140 is the easy transition to CPAP when HFOT is not enough. Our Doctors reported positive results with CPAP when treating COVID-19.”
Agustin Martin, Martin Vecino, Spain.
The FD140 features again in the below news clip of a coronavirus patient extubation at the Hospital Clinico de Madrid (right).
In the presentation below, Nigel Armstrong reviews recent clinical evidence supporting CPAP as a treatment method for COVID-19 patients with ARDS.